ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Kennedy To Stay On Health Committee; Animal Research Bills Probably Dead For This Congress

December 10, 1982

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

In Brief: NCI May Support Studies Of Heat As Therapeutic Method DTIC OK Near for Malignant Melanoma

May 16, 1975

Funding opportunities listed.

November 12, 2004

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995